Join Zoom Meeting https://zoom.us/j/94014152578?pwd=RXhIREZyT0wrWDRyT3YyQng4ZkR0QT09 Meeting ID: 940 1415 2578 Passcode: 950930
New viral respiratory pathogens are emerging with increasing frequency and have potentially devastating impacts on the population worldwide. Recent examples of newly emerged threats include severe acute respiratory syndrome coronavirus(SARS), the 2009 H1N1 influenza pandemic (SWINE FLU), and Middle East respiratory syndrome coronavirus(MERS) and the latest was COVID-19. These infections have a risk of death ranging from 10-40% and can cause disease with a variable severity. We know from our COVID-19 outbreak that majority of infected people had nil to very mild symptoms while some suffered life threatening illness.
It’s impossible to know how your body will react to when faced a viral threat. The only thing that can protect us all is knowledge about illness spread and precautions that we can take to prevent ourselves from getting infected.
With this thought in mind, SUHRC and SMCW have invited Dr Jean Marshall, Clinical Research manager at Fisher- Paykel Healthcare, New Zealand. Her career has focused on the development of medical devices across diverse disciplines. At the start of the COVID-19 pandemic, Dr Marshall’s research pivoted to investigate the impact respiratory therapies may have on airborne spread of disease. Her team of eight built on the emerging evidence of airborne transmission, developing their own gold standard methods to understand respiratory aerosols and, importantly, visualise respiratory plumes. Knowledge of the airborne nature of disease has changed dramatically during the pandemic, this talk will ensure attendees are aware of the paradigm shift to better acknowledging airborne transmission of disease”
Her talk is supported by Fisher- Paykel, India. Established in 1969, Fisher & Paykel Healthcare was built on a vision to provide active heated humidification of gases needed for critically ill patients requiring intubation and mechanical ventilation. Fisher & Paykel specialise in humidifier and circuits used in neonates, paediatric and adult patients in both invasive and non-invasive ventilation. Fisher & Paykel has a large presence in delivery room and neonatal respiratory care respiratory care with infant resuscitators as well as specifically designed bubble CPAP systems
Over the past 15-20yrs, the development of unique heated & humidified high flow generators called Airvo and the High Flow Nasal Cannula called Optiflow, has led to significant clinical practice change and improved patient outcomes and creation of clinical practice guidelines in primary respiratory support in neonate, paediatric and adult respiratory care management therapies and in addition provide homecare respiratory support devices such as CPAP for Obstructive Sleep Apnoea
This talk is hosted by Dr Urvi Shukla, Head of Critical Care at Symbiosis University Hospital and Research Centre. She is a Clinician Researcher with 25 years of dedicated work in Critical Care.
